Top Markets
#1 Wrapped STX (Velar) Wrapped STX (Velar) +47.40%
#2 Pons Pons +35.27%
#3 Purr Purr +33.42%
#4 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +29.57%
#5 TENDIES TENDIES +28.48%
#6 Starpower Starpower +28.34%
#7 StonkBroker StonkBroker +23.34%
#8 SkyAI SkyAI +23.33%
#9 PondCoin PondCoin +22.89%
#10 Magma Finance Magma Finance +22.43%
Coin of the day
Wrapped STX (Velar) Wrapped STX (Velar)
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Merck & Co., Inc. Merck & Co., Inc.

Merck & Co., Inc.

MRK
Classifica tra le azioni #40
Merck & Co., Inc. is a global healthcare leader with operations spanning two... Merck & Co., Inc. is a global healthcare leader with operations spanning two core divisions: Pharmaceuticals and Animal Health. The Pharmaceutical segment is dedicated to human health, offering a broad spectrum of medicinal products. These cover crucial therapeutic areas such as oncology, acute hospital care, immunology, neuroscience, virology, cardiovascular conditions, and diabetes. This division also develops vital preventive vaccines for pediatric, adolescent, and adult populations. Meanwhile, the Animal Health segment focuses on the research, development, manufacturing, and marketing of veterinary medications, vaccines, and comprehensive health management solutions for animals. This division further provides innovative digital products designed for animal identification, traceability, and continuous monitoring. Merck's extensive clientele encompasses drug wholesalers, pharmacies, hospitals, and government agencies. It also serves managed healthcare organizations, including health maintenance organizations (HMOs) and pharmacy benefit managers, as well as various other institutional clients. Additionally, the company supplies products to individual physicians and their distributors, veterinarians, and livestock producers. The organization actively engages in strategic collaborations with companies such as AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc. These partnerships are specifically aimed at the joint development and commercialization of prolonged-acting therapies for HIV. Established in 1891, Merck & Co., Inc. maintains its corporate headquarters in Kenilworth, New Jersey.
Prezzo delle azioni
$152.40
Capitalizzazione di mercato
$376.40B
Variazione (1 giorno)
12.48%
Variazione (1 anno)
79.44%
Paese
US
Scambia Merck & Co., Inc. (MRK)

Categoria

Healthcare
Rapporto P/B per Merck & Co., Inc. (MRK)
Rapporto P/B al August 2026 TTM: 8.01
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Merck & Co., Inc., il rapporto P/B attuale (TTM) è 8.01. Alla fine del 2024, era pari a 5.44.
Storico del rapporto P/B per Merck & Co., Inc. da 2000 a 2026
Rapporto P/B alla fine di ogni anno
Anno Rapporto P/B Cambia
2026 (TTM) 8.01 57.64%
2025 5.08 -6.51%
2024 5.44 -28.09%
2023 7.56 23.82%
2022 6.11 20.29%
2021 5.08 -34.85%
2020 7.79 -9.22%
2019 8.59 21.37%
2018 7.07 67.90%
2017 4.21 9.48%
2016 3.85 22.74%
2015 3.14 -0.75%
2014 3.16 12.54%
2013 2.81 25.96%
2012 2.23 11.14%
2011 2.01 2.50%
2010 1.96 57.27%
2009 1.24 -62.32%
2008 3.30 -50.09%
2007 6.61 28.29%
2006 5.16 39.08%
2005 3.71 -5.78%
2004 3.93 -37.81%
2003 6.33 -5.53%
2002 6.70 -16.24%
2001 7.99 -42.42%
2000 13.88 0.00%
Rapporto P/B per aziende simili o concorrenti
Azienda Rapporto P/B Differenza del rapporto P/B Il paese
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 31.0864 288.19%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7.4766 -6.64%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 -74.4354 -1,029.51%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 8.4776 5.86%
CH
Novartis AG Novartis AG
Novartis AG
NOVN.SW
 6.754 -15.66%
CH